Decreased Bone Mineral Density Is a Predictor of Poor Survival in Critically Ill Patients.
clinical/novel biomarkers
intensive care medicine
osteoporosis
sepsis infections
survival
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
23 Aug 2021
23 Aug 2021
Historique:
received:
11
07
2021
revised:
09
08
2021
accepted:
17
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
Alterations in bone mineral density (BMD) have been suggested as independent predictors of survival for several diseases. However, little is known about the role of BMD in the context of critical illness and intensive care medicine. We therefore evaluated the prognostic role of BMD in critically ill patients upon admission to an intensive care unit (ICU). Routine computed tomography (CT) scans of 153 patients were used to assess BMD in the first lumbar vertebra. Results were correlated with clinical data and outcomes. While median BMD was comparable between patients with and without sepsis, BMD was lower in patients with pre-existing arterial hypertension or chronic obstructive pulmonary disease. A low BMD upon ICU admission was significantly associated with impaired short-term ICU survival. Moreover, patients with baseline BMD < 122 HU had significantly impaired overall survival. The prognostic relevance of low BMD was confirmed in uni- and multivariate Cox-regression analyses including several clinicopathological parameters. In the present study, we describe a previously unrecognised association of individual BMD with short- and long-term outcomes in critically ill patients. Due to its easy accessibility in routine CT, BMD provides a novel prognostic tool to guide decision making in critically ill patients.
Identifiants
pubmed: 34442036
pii: jcm10163741
doi: 10.3390/jcm10163741
pmc: PMC8397072
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Horizon 2020
ID : 771083
Organisme : Wellcome Trust
ID : 110043
Pays : United Kingdom
Organisme : Deutsche Forschungsgemeinschaft
ID : SFB-TRR57/P06
Organisme : Deutsche Forschungsgemeinschaft
ID : LU 1360/3-1
Organisme : Deutsche Forschungsgemeinschaft
ID : CRC1380/A01
Organisme : Deutsche Forschungsgemeinschaft
ID : CA 830/3-1
Références
Clin Nutr. 2019 Dec;38(6):2770-2777
pubmed: 30595376
J Clin Endocrinol Metab. 2014 May;99(5):1834-42
pubmed: 24606086
Anticancer Res. 2018 Nov;38(11):6465-6471
pubmed: 30396973
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):89-101
pubmed: 27897405
Int J Mol Sci. 2016 Jan 09;17(1):
pubmed: 26761003
Anaesthesiol Intensive Ther. 2021;53(1):10-17
pubmed: 33625819
Osteoporos Int. 2001;12(4):259-65
pubmed: 11420774
J Bone Miner Res. 2007 Mar;22(3):465-75
pubmed: 17144789
Radiology. 2019 May;291(2):360-367
pubmed: 30912719
Liver Int. 2018 May;38(5):776-785
pubmed: 29479832
Osteoporos Int. 2021 Feb;32(2):301-309
pubmed: 32827276
J Bone Miner Res. 2014 Nov;29(11):2520-6
pubmed: 24771492
Ann Saudi Med. 2021 Mar-Apr;41(2):101-108
pubmed: 33818146
Int J Cardiol. 2013 Jun 20;166(2):385-93
pubmed: 22112679
Liver Transpl. 2016 Aug;22(8):1092-8
pubmed: 27064263
Circulation. 2020 Jan 21;141(3):234-236
pubmed: 31958246
Nat Rev Rheumatol. 2012 Oct;8(10):587-98
pubmed: 22890244
Eur Respir J Suppl. 2003 Nov;46:64s-75s
pubmed: 14621108